Published in Cancer Immunol Immunother on January 01, 1989
Peptide-binding specificity of the molecular chaperone BiP. Nature (1991) 4.36
The neuron-specific protein PGP 9.5 is a ubiquitin carboxyl-terminal hydrolase. Science (1989) 3.84
Long-term outcome after argon plasma coagulation of small-bowel lesions using double-balloon enteroscopy in patients with mid-gastrointestinal bleeding. Endoscopy (2011) 3.20
RXR alpha, a promiscuous partner of retinoic acid and thyroid hormone receptors. EMBO J (1992) 3.03
Low back pain associated with streptokinase. Lancet (1992) 2.85
14-3-3zeta binds a phosphorylated Raf peptide and an unphosphorylated peptide via its conserved amphipathic groove. J Biol Chem (1998) 2.07
A monoclonal antibody to a novel differentiation antigen on human macrophages associated with the down-regulatory phase of the inflammatory process. Exp Cell Biol (1987) 1.86
Prescribing patterns of nurse practitioners. Am J Nurs (1982) 1.82
Trial of oral miltefosine for visceral leishmaniasis. Lancet (1998) 1.58
CAP37, a human neutrophil-derived chemotactic factor with monocyte specific activity. J Clin Invest (1990) 1.46
Synthetic bactericidal peptide based on CAP37: a 37-kDa human neutrophil granule-associated cationic antimicrobial protein chemotactic for monocytes. Proc Natl Acad Sci U S A (1993) 1.45
Identification of the primary antimicrobial domains in human neutrophil cathepsin G. J Biol Chem (1990) 1.38
Prostacyclin deficiency in thrombotic thrombocytopenic purpura. Lancet (1979) 1.27
Experimental vitamin K deficiency and spontaneous metastases. Br J Cancer (1977) 1.26
The C-terminal tail of UNC-60B (actin depolymerizing factor/cofilin) is critical for maintaining its stable association with F-actin and is implicated in the second actin-binding site. J Biol Chem (2000) 1.24
Analysis of Qa-1(b) peptide binding specificity and the capacity of CD94/NKG2A to discriminate between Qa-1-peptide complexes. J Exp Med (2000) 1.23
Heterogeneity of the purified extracellular aspartyl proteinase from Candida albicans: characterization with monoclonal antibodies and N-terminal amino acid sequence analysis. Infect Immun (1993) 1.17
Analytical performance characteristics and clinical utility of a novel assay for total hepatitis C virus core antigen quantification. J Clin Microbiol (2010) 1.16
Identification of the active site cysteine and of the disulfide bonds in the N-terminal part of the molecule of bovine spleen cathepsin B. FEBS Lett (1982) 1.15
The effect of heparin on the initial phase of metastasis formation. Eur J Cancer (1972) 1.15
Distinct proteomic profiles of amphetamine self-administration transitional states. Pharmacogenomics J (2005) 1.12
Human lysosomal cathepsin G and granzyme B share a functionally conserved broad spectrum antibacterial peptide. J Biol Chem (1991) 1.12
Acrolein, the causative factor of urotoxic side-effects of cyclophosphamide, ifosfamide, trofosfamide and sufosfamide. Arzneimittelforschung (1979) 1.11
Purification and characterization of an interleukin-1beta-converting enzyme family protease that activates cysteine protease P32 (CPP32). J Biol Chem (1996) 1.11
Experimental hypercalcaemia and whole blood clotting. J Clin Pathol (1973) 1.10
Cyclic AMP-dependent protein kinase phosphorylates group III metabotropic glutamate receptors and inhibits their function as presynaptic receptors. J Neurochem (2001) 1.09
Unique autolytic cleavage of human myeloperoxidase. Implications for the involvement of active site MET409. J Biol Chem (1992) 1.08
Identification of specific sites in human P-glycoprotein phosphorylated by protein kinase C. J Biol Chem (1993) 1.07
Studies on the urotoxicity of oxazaphosphorine cytostatics and its prevention--III. Profile of action of sodium 2-mercaptoethane sulfonate (mesna). Eur J Cancer Clin Oncol (1982) 1.06
Cell death during autoimmune demyelination: effector but not target cells are eliminated by apoptosis. J Immunol (1997) 1.06
Cloning and expression of an NADP(+)-dependent alcohol dehydrogenase gene of Entamoeba histolytica. Proc Natl Acad Sci U S A (1992) 1.06
The ontogeny of a 57-Kd cationic antimicrobial protein of human polymorphonuclear leukocytes: localization to a novel granule population. Blood (1990) 1.04
Synthetic peptides of human lysosomal cathepsin G with potent antipseudomonal activity. Infect Immun (1993) 1.03
Activation of MAP kinases and phosphorylation of caldesmon in canine colonic smooth muscle. J Physiol (1996) 1.03
Oral anticoagulation in the treatment of a spontaneously metastasising murine tumour (3LL). Br J Cancer (1977) 1.01
Bactericidal activity of a synthetic peptide (CG 117-136) of human lysosomal cathepsin G is dependent on arginine content. Infect Immun (1996) 1.01
Proteomic identification of the wt-p53-regulated tumor cell secretome. Oncogene (2006) 1.01
Ifosfamide--current aspects and perspectives. Cancer Treat Rev (1983) 1.01
Hexadecylphosphocholine, a new ether lipid analogue. Studies on the antineoplastic activity in vitro and in vivo. Acta Oncol (1989) 0.99
Cloning of a new member of the TGF-beta family: a putative new activin beta C chain. Biochem Biophys Res Commun (1995) 0.98
Bone morphogenetic proteins and growth and differentiation factors in the human cornea. Invest Ophthalmol Vis Sci (1999) 0.98
Studies on the urotoxicity of oxazaphosphorine cytostatics and its prevention. 2. Comparative study on the uroprotective efficacy of thiols and other sulfur compounds. Eur J Cancer Clin Oncol (1981) 0.98
Chemical stability and fate of the cytostatic drug ifosfamide and its N-dechloroethylated metabolites in acidic aqueous solutions. J Med Chem (1999) 0.96
ABRF ESRG 2005 study: identification of seven modified amino acids by Edman sequencing. J Biomol Tech (2006) 0.96
Dicynthaurin: an antimicrobial peptide from hemocytes of the solitary tunicate, Halocynthia aurantium. Biochim Biophys Acta (2001) 0.96
cAMP-dependent protein kinase inhibits mGluR2 coupling to G-proteins by direct receptor phosphorylation. J Neurosci (2000) 0.96
The role of blood platelets in experimental metastases. Br J Cancer (1973) 0.95
Time course and cellular localization of interleukin-10 mRNA and protein expression in autoimmune inflammation of the rat central nervous system. Am J Pathol (1998) 0.95
Protein kinase domain of twitchin has protein kinase activity and an autoinhibitory region. J Biol Chem (1994) 0.95
The development of mesna for regional detoxification. Cancer Treat Rev (1983) 0.94
Surgical ligation vs. angiographic embolization of the vena spermatica: a prospective randomized study for the treatment of varicocele-related infertility. Andrologia (1993) 0.94
Photoinactivation of skin fibroblasts by fractionated treatment with 8-methoxypsoralen and UVA. J Invest Dermatol (1979) 0.94
Microangiopathic haemolytic anaemia and experimental tumour-cell emboli. Br J Haematol (1974) 0.94
CAP 37, a 37 kD human neutrophil granule cationic protein shares homology with inflammatory proteinases. Life Sci (1990) 0.94
Transnasal endoscopy for direct visual control of esophageal stent placement without fluoroscopy. Endoscopy (2012) 0.93
Hexadecylphosphocholine in the topical treatment of skin metastases in breast cancer patients. Prog Exp Tumor Res (1992) 0.93
ABRF ESRG 2006 study: Edman sequencing as a method for polypeptide quantitation. J Biomol Tech (2007) 0.93
D-19575--a sugar-linked isophosphoramide mustard derivative exploiting transmembrane glucose transport. Cancer Chemother Pharmacol (1995) 0.93
Pharmacokinetics and mechanism of action of detoxifying low-molecular-weight thiols. J Cancer Res Clin Oncol (1984) 0.92
Characterization of the antitumor activity of hexadecylphosphocholine (D 18506). Eur J Cancer Clin Oncol (1988) 0.92
The influence of platelet aggregation inhibitors on metastasis formation in mice (3LL). Z Krebsforsch Klin Onkol Cancer Res Clin Oncol (1976) 0.92
Child sexual abuse prevention: evaluation and one-year follow-up. Child Abuse Negl (1991) 0.92
Cloning and expression of recombinant human growth/differentiation factor 5. Biochem Biophys Res Commun (1994) 0.92
Caldesmon and calponin phosphorylation in regulation of smooth muscle contraction. Can J Physiol Pharmacol (1994) 0.91
Detoxification of urotoxic oxazaphosphorines by sulfhydryl compounds. J Cancer Res Clin Oncol (1981) 0.91
Gene trapping identifies inhibitors of oncogenic transformation. The tissue inhibitor of metalloproteinases-3 (TIMP3) and collagen type I alpha2 (COL1A2) are epidermal growth factor-regulated growth repressors. J Biol Chem (1998) 0.91
Pharmacokinetics and metabolism of sodium 2-mercaptoethanesulfonate in the rat. Cancer Res (1983) 0.91
Anticancer agents coupled to N-(2-hydroxypropyl)methacrylamide copolymers. I. Evaluation of daunomycin and puromycin conjugates in vitro. Br J Cancer (1987) 0.90
Microangiopathic haemolytic anaemia associated with hypercalcaemia in an experimental rat tumour. Br J Haematol (1973) 0.90
Anticoagulants in the treatment of cancer. Eur J Cancer (1976) 0.90
Acute hypercalcemia due to Walker carcinosarcoma 256 in the rat. Horm Metab Res (1970) 0.89
Aspirin and tumour metastasis. Lancet (1972) 0.89
Trophic and protective effects of growth/differentiation factor 5, a member of the transforming growth factor-beta superfamily, on midbrain dopaminergic neurons. J Neurosci Res (1995) 0.89
Amino acid sequence of bovine spleen cathepsin B. J Biol Chem (1988) 0.88
Platelet shape change abnormalities in diabetic retinopathy. Diabetologia (1980) 0.88
Growth/differentiation factor 5 and glial cell line-derived neurotrophic factor enhance survival and function of dopaminergic grafts in a rat model of Parkinson's disease. Eur J Neurosci (1998) 0.88
[Experiences with pneumatic cardial dilatation in achalasia]. Schweiz Med Wochenschr (1969) 0.88
Phosphorylation by protein kinase C and cyclic AMP-dependent protein kinase of synthetic peptides derived from the linker region of human P-glycoprotein. Biochem J (1994) 0.88
Angiography-based C-arm CT for the assessment of extrahepatic shunting before radioembolization. Rofo (2010) 0.87
Inactivation of aldophosphamide by human aldehyde dehydrogenase isozyme 3. Biochem Pharmacol (2000) 0.87
Hexadecylphosphocholine: determination of serum concentrations in rats. J Lipid Mediat (1992) 0.87
Factor X-activating activity from Lewis lung carcinoma. Br J Cancer (1980) 0.87
A novel casein kinase 2 alpha-subunit regulates membrane protein traffic in the human hepatoma cell line HuH-7. J Biol Chem (2000) 0.87
A phase I study of 1,2-diamminomethyl-cyclobutane-platinum (II)-lactate (D-19466; lobaplatin) administered daily for 5 days. Br J Cancer (1993) 0.87
Priapism: a three-phase concept of management according to aetiology and prognosis. Br J Urol (1986) 0.87
Purification and characterization of heme oxygenase from chick liver. Comparison of the avian and mammalian enzymes. Eur J Biochem (1990) 0.87
Differential expression of interleukin-10 mRNA in Wallerian degeneration and immune-mediated inflammation of the rat peripheral nervous system. J Neurosci Res (1996) 0.87
Changes of intracellular calcium, fatty acids and phospholipids during miltefosine-induced apoptosis monitored by fluorescence- and 13C NMR-spectroscopy. Anticancer Res (2000) 0.86
African-American women who smoke crack cocaine: sexual trauma and the mother-daughter relationship. J Psychoactive Drugs (1995) 0.86
Indications for the presence of an atypical protease-activated receptor on rat platelets. Ann Hematol (2000) 0.86
High-dose ifosfamide and mesna as continuous infusion over five days--a phase I/II trial. Cancer Treat Rev (1983) 0.85
Severe paraneoplastic gastroparesis associated with anti-Hu antibodies preceding the manifestation of small-cell lung cancer. Z Gastroenterol (2008) 0.85
Mechanistic aspects of the cytotoxic activity of glufosfamide, a new tumour therapeutic agent. Br J Cancer (2000) 0.85
Pharmacokinetics and whole-body distribution of the new chemotherapeutic agent beta-D-glucosylisophosphoramide mustard and its effects on the incorporation of [methyl-3H]-thymidine in various tissues of the rat. Cancer Chemother Pharmacol (1996) 0.84
Reversible tumorigenesis in mice by conditional expression of the HER2/c-erbB2 receptor tyrosine kinase. Oncogene (1996) 0.84
Mechanism of lung tumour colony reduction caused by coumarin anticoagulation. Eur J Cancer (1979) 0.84
[Intravascular coagulation in solid Walker carcinosarcoma 256]. Schweiz Med Wochenschr (1971) 0.84
Subunit structure and function of porcine factor Xa-activated factor VIII. Biochemistry (1997) 0.84
Activation of MAP kinases in airway smooth muscle. Am J Physiol (1997) 0.84